Glenmark receives US FDA approval for zolmitriptan tablets & z...

Global Information Inc. would like to present a new market research report, "PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013" by GlobalData. Increase in ...

Glenmark Pharmaceuticals rose 1% to Rs 498.20 at 12:38 IST on BSE as the company on Friday, 15 March 2013, said that its subsidiary Glenmark Generics has filed an abbreviated new drug application with USFDA for a generic version of FINACEA. The ...

HYDERABAD: Glenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg), used in treatment of chronic asthma and prophylaxis, on "off-odour" complaints, according to . Montelukast Sodium tablets are ...

Glenmark Generics Limited, a generic pharmaceutical company, has filed an abbreviated new drug application, or ANDA, for Azelaic Acid, Gel 15% Topical, with the FDA with a Paragraph IV Certification for the Orange-Book listed patent. Glenmark's ANDA ...

A unit of Bayer AG (BAYN), Germany's largest drugmaker, sued India's Glenmark Generics Ltd. seeking to stop sales of a generic form of its Finacea gel used to treat rosacea. Glenmark, based in Mumbai, is seeking U.S. Food and Drug Administration ...

US-based MSD Pharma, the third-largest pharma company in the world by revenues, has asked the Delhi High Court to bar Mumbai-based Glenmark from selling two popular anti-diabetic drugs, triggering yet another legal battle between an Indian generic ...

By R. Jai Krishna NEW DELHI--Merck & Co.'s ( Merck & Co., Inc.) This is the latest among a series of legal disputes in India between multinational pharmaceutical companies which want to protect their patents and local generics drug makers that sell ...

Dr Reddy's Laboratories has recalled its anti-depression drug Citalopram from the US market, following complaints of a strong odour. Mumbai-based Glenmark Pharmaceuticals too recalled its allergy and asthma drug in February, after reports that some ...

Related to : Glenmark Pharmaceuticals Ltd Glenmark Pharmaceuticals Ltd BSE 15 May 13 | 04:00 PM 558.25 10.6 (1.94%) NSE 15 May 13 | 03:47 PM 561.60 13 (2.37%) Glenmark Pharmaceuticals Ltd today said its subsidiary has received approval from the ...